- Home
- RAND vs DXR Comparison
RAND vs DXR Comparison
Compare RAND & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- DXR
- Stock Information
- Founded
- RAND 1969
- DXR 1970
- Country
- RAND United States
- DXR United States
- Employees
- RAND N/A
- DXR N/A
- Industry
- RAND Finance: Consumer Services
- DXR Medical/Dental Instruments
- Sector
- RAND Finance
- DXR Health Care
- Exchange
- RAND Nasdaq
- DXR Nasdaq
- Market Cap
- RAND 47.5M
- DXR 42.6M
- IPO Year
- RAND N/A
- DXR N/A
- Fundamental
- Price
- RAND $17.06
- DXR $8.24
- Analyst Decision
- RAND
- DXR Strong Buy
- Analyst Count
- RAND 0
- DXR 1
- Target Price
- RAND N/A
- DXR $24.75
- AVG Volume (30 Days)
- RAND 12.6K
- DXR 23.1K
- Earning Date
- RAND 11-06-2024
- DXR 01-01-0001
- Dividend Yield
- RAND 29.48%
- DXR N/A
- EPS Growth
- RAND 123.39
- DXR N/A
- EPS
- RAND 4.98
- DXR 0.35
- Revenue
- RAND $8,351,941.00
- DXR $154,205.00
- Revenue This Year
- RAND N/A
- DXR N/A
- Revenue Next Year
- RAND N/A
- DXR N/A
- P/E Ratio
- RAND $3.42
- DXR $23.96
- Revenue Growth
- RAND 16.96
- DXR N/A
- 52 Week Low
- RAND $12.81
- DXR $7.19
- 52 Week High
- RAND $24.10
- DXR $10.04
- Technical
- Relative Strength Index (RSI)
- RAND 42.96
- DXR 40.06
- Support Level
- RAND $18.67
- DXR $8.04
- Resistance Level
- RAND $24.10
- DXR $8.42
- Average True Range (ATR)
- RAND 1.34
- DXR 0.36
- MACD
- RAND -0.26
- DXR -0.09
- Stochastic Oscillator
- RAND 9.63
- DXR 14.47
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.